MannKind Corporation investor relations material

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza (insulin human), a small molecule inhalation powder that delivers rapid insulin absorption directly into the bloodstream. Its product portfolio also includes Technosphere dry powder inhalation system and pulmonary delivery devices.